157 related articles for article (PubMed ID: 4126721)
1. Survival and relapse rates in Hodgkin's disease: Stanford experience, 1961-71.
Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():487-96. PubMed ID: 4126721
[No Abstract] [Full Text] [Related]
2. Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin's disease.
Tubiana M; van der Werf-Messing B; Laugier A; Hayat M; Henry-Amar M; Attie E; Leroy T
Natl Cancer Inst Monogr; 1973 May; 36():513-30. PubMed ID: 4744607
[No Abstract] [Full Text] [Related]
3. Analysis of primary relapses after radiotherapy in Hodgkin's disease.
Spittle MF; Harmer CL; Cassady JR; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():497-508. PubMed ID: 4744605
[No Abstract] [Full Text] [Related]
4. International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
Kaplan HS; Rosenberg SA
Natl Cancer Inst Monogr; 1973 May; 36():363-71. PubMed ID: 4582994
[No Abstract] [Full Text] [Related]
5. Current studies in Hodgkin's disease: what laparotomy has wrought.
Hellman S
N Engl J Med; 1974 Apr; 290(16):894-8. PubMed ID: 4593613
[No Abstract] [Full Text] [Related]
6. Hodgkin's disease: survival and relapse-free data.
Smithers DW
Natl Cancer Inst Monogr; 1973 May; 36():509-12. PubMed ID: 4744606
[No Abstract] [Full Text] [Related]
7. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
DeVita VT
Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
[No Abstract] [Full Text] [Related]
8. [Treatment and prognosis of intrathoracic Hodgkin's disease (author's transl)].
Jungblut R; Menne HJ
Dtsch Med Wochenschr; 1975 May; 100(22):1219-24. PubMed ID: 1132336
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin's and non-Hodgkin's lymphomas.
McElwain TJ
Br J Hosp Med; 1984 Jan; 31(1):10-4, 18-9. PubMed ID: 6697038
[No Abstract] [Full Text] [Related]
10. Results of treating Hodgkin's disease without a policy of laparotomy staging.
Bergsagel DE; Alison RE; Bean HA; Brown TC; Bush RS; Clark RM; Chua T; Dalley D; DeBoer G; Gospodarowicz M; Hasselback R; Perrault D; Rideout DF
Cancer Treat Rep; 1982 Apr; 66(4):717-31. PubMed ID: 7074642
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P
Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease. Results from a program in radiation therapy.
Micaily B; Brady LW
Am J Clin Oncol; 1984 Apr; 7(2):159-71. PubMed ID: 6422736
[TBL] [Abstract][Full Text] [Related]
14. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
16. Progress report. Hodgkin's clinical trial, 1972.
Hutchison GB
Natl Cancer Inst Monogr; 1973 May; 36():387-93. PubMed ID: 4582997
[No Abstract] [Full Text] [Related]
17. Treatment of Hodgkin's disease.
Med Lett Drugs Ther; 1974 Aug; 16(17):69-71. PubMed ID: 4135467
[No Abstract] [Full Text] [Related]
18. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
19. [Causes for failures in the treatment of localized forms of lymphogranulomatosis].
Pakulina LE; Chekharina EA
Vopr Onkol; 1973 May; 19(5):36-41. PubMed ID: 4714734
[No Abstract] [Full Text] [Related]
20. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]